Linked Life Data

18774442

Source:http://linkedlifedata.com/resource/pubmed/id/18774442

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3 Suppl
pubmed:dateCreated
2008-9-8
pubmed:abstractText
Historically Parkinson's disease (PD) has been treated primarily with oral agents, with patients learning quickly that their clinical response is tied closely to their level of medication compliance. Studies, however, have found that compliance is less than ideal, and erratic medication consumption is commonplace. When prescribing antiparkinsonian therapies, the clinician should consider ease of administration, tolerability, and efficacy, along with other factors that are likely to contribute to optimal compliance by the patient.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0733-8619
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S45-63, vi
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Assessing the impact of ease of administration and tolerability on treatment choices in Parkinson's disease.
pubmed:affiliation
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Elder Services/Visiting Nurses Association, 5125 North Market Street, Spokane, WA 99217-6131, USA. ssetter@smhca.org
pubmed:publicationType
Journal Article, Review